Pharmaceutical composition for vaccine against tuberculosis having enhanced protective efficacy

摘要

The present invention relates to a pharmaceutical composition for improving tuberculosis with enhanced immunity, and more particularly, to a pharmaceutical composition for tuberculous vaccine improved immunological effect, and more particularly, to a cosmetic composition obtained by co-culturing Mycobacterium bovis BCG and mesenchymal stem cells The present invention relates to a pharmaceutical composition for enhancing an immune effect comprising water as an active ingredient. The present invention uses a vaccine of a co-culture product of Mycobacterium bovis BCG and a mesenchymal stem cell, which is known as a general tuberculosis vaccine, to significantly improve the tuberculosis defense function as compared with the case of using the above Mycobacterium bovis BCG alone Can effectively prevent or delay the onset of tuberculosis.